Funding for this research was provided by:
Received: 20 November 2018
Accepted: 18 March 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: Independent ethics committee and hospital-based institutional review board approvals were obtained, as necessary, for the registry protocol.
: Not applicable.
: JB-W has received grants and personal fees from Bayer, Daiichi, Janssen, Pfizer and Portola and has received grants from Boehringer. AJC has received personal fees from Bayer, Boehringer Ingelheim, Pfizer/BMS, Daiichi Sankyo, Portola and Verseon and has received grants from Bayer, Boehringer Ingelheim, Pfizer/BMS and Daiichi Sankyo. KAAF has received grants and personal fees from Bayer/Janssen and AstraZeneca and personal fees from Sanofi/Regeneron and Verseon outside the submitted work. JYLH has received personal fee from AstraZeneca, Bayer, Boehringer Ingelheim, BMS/Pfizer, Daiichi Sankyo, Meda, Sanofi, and Servier. SH has received personal fees from Aspen, Bayer Healthcare, BMS/Pfizer, Daiichi-Sankyo, Portola and Sanofi. AGGT has received personal fees from Bayer Healthcare, Janssen Pharmaceutical Research & Development LLC, Astellas, Portola, and Takeda.SV has no disclosures. AKK has received research support from Bayer AG; personal fees from Bayer AG, Boehringer-Ingelheim Pharma, Daiichi Sankyo Europe, Janssen Pharma, Sanofi SA and Verseon.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.